Retatrutide FDA status and TRIUMPH

Research-use notice: This article is laboratory and educational information only. It is not medical or legal advice, and it does not include how-to-use instructions. BlueNex Labs materials are research-use only and are not intended for human or veterinary use. Research-use-only labeling is not a Health Canada authorization.

Retatrutide (LY3437943) is an investigational triple agonist at GLP-1, GIP, and glucagon receptors, developed by Eli Lilly. As of the status check for this article, it is not FDA-approved and is not a Health Canada-authorized medicine. This page tracks public regulatory status. It is not the shop listing.

What “investigational” means

Public sources describe an IND-stage programme and Phase 3 work under the TRIUMPH name. An advisory article or blog that calls retatrutide “approved” is incorrect until a regulator issues that decision. An NDA timeline in secondary media is a forecast, not a catalog fact.

What trials are designed to measure

Registered studies evaluate metabolic endpoints such as glycemic markers and body-weight change in defined cohorts, plus safety. Reporting a trial endpoint is not the same as advertising a consumer outcome. For a longer recap of published numbers see retatrutide clinical trial notes and the late-stage diabetes readout recap.

Laboratory lots

Size-specific research fills, when stocked, are documented on the retatrutide catalog page and in the retatrutide COA section (10 mg, 20 mg, and 30 mg are different lots). Those pages are for laboratory purchasing. They are not Lilly trial drug and they are not a prescription product.

How to use this note with the catalog

A research vial on this catalog is not the investigational trial supply. Confirm lot identity on the COA before an assay, and do not treat secondary media timelines as a purchasing specification.

Orders ship inside Canada only after Interac e-Transfer checkout. Sold-out SKUs remain listed and cannot be added to the cart. Match each vial to its own Certificate of Analysis when a lot is published. Research-use only. Not for human or veterinary use.